Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 263757, 10 pages
http://dx.doi.org/10.1155/2013/263757
Research Article

Metabolomic Analysis of Complex Chinese Remedies: Examples of Induced Nephrotoxicity in the Mouse from a Series of Remedies Containing Aristolochic Acid

1Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei 106, Taiwan
2The Metabolomics Core Laboratory, Center of Genomic Medicine, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei 106, Taiwan
3Institute of Toxicology, College of Medicine, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei 106, Taiwan
4Department of Pharmacy, College of Medicine, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei 106, Taiwan
5Department of Computer Science and Information Engineering, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei 106, Taiwan
6Sheng Chang Pharmaceutical Co., Ltd., Jung-Li, Taiwan

Received 8 January 2013; Revised 26 February 2013; Accepted 27 February 2013

Academic Editor: Mark Moss

Copyright © 2013 Dong-Ming Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U. Mengs, “Acute toxicity of aristolochic acid in rodents,” Archives of Toxicology, vol. 59, no. 5, pp. 328–331, 1987. View at Google Scholar · View at Scopus
  2. F. D. Debelle, J. L. Vanherweghem, and J. L. Nortier, “Aristolochic acid nephropathy: a worldwide problem,” Kidney International, vol. 74, no. 2, pp. 158–169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Hashimoto, M. Higuchi, B. Makino et al., “Quantitative analysis of aristolochic acids, toxic compounds, contained in some medicinal plants,” Journal of Ethnopharmacology, vol. 64, no. 2, pp. 185–189, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Cheung, C. Xue, K. Leung, K. Chan, and C. Li, “Aristolochic acids detected in some raw Chinese medicinal herbs and manufactured herbal products—a consequence of inappropriate nomenclature and imprecise labelling?” Clinical Toxicology, vol. 44, no. 4, pp. 371–378, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. V. M. Arlt, M. Stiborova, and H. H. Schmeiser, “Aristolochic acid as a probable human cancer hazard in herbal remedies: a review,” Mutagenesis, vol. 17, no. 4, pp. 265–277, 2002. View at Google Scholar · View at Scopus
  6. M. Heinrich, J. Chan, S. Wanke, C. Neinhuis, and M. S. J. Simmonds, “Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2-A global assessment based on bibliographic sources,” Journal of Ethnopharmacology, vol. 125, no. 1, pp. 108–144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. L. Vanherweghem, M. Depierreux, C. Tielemans et al., “Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs,” The Lancet, vol. 341, no. 8842, pp. 387–391, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Vanherweghem, F. Debelle, M. C. Muniz-Martinez, and J. Nortier, “Aristolochic acid nephropathy after Chinese herbal remedies,” in Clinical Nephrotoxins, pp. 579–586, Kluwer Academic, New York, NY, USA, 2nd edition, 2004. View at Google Scholar
  9. J. L. Nortier, M. C. M. Martinez, H. H. Schmeiser et al., “Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi),” The New England Journal of Medicine, vol. 342, no. 23, pp. 1686–1692, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Gillerot, M. Jadoul, V. M. Arlt et al., “Aristolochic acid nephropathy in a Chinese patient: time to abandon the term “Chinese herbs nephropathy”?” American Journal of Kidney Diseases, vol. 38, no. 5, p. E26, 2001. View at Google Scholar · View at Scopus
  11. J. L. Nortier and J. L. Vanherweghem, “For patients taking herbal therapy—lessons from aristolochic acid nephropathy,” Nephrology Dialysis Transplantation, vol. 22, no. 6, pp. 1512–1517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. J. Martena, J. C. A. Van Der Wielen, L. F. J. Van De Laak, E. J. M. Konings, H. N. De Groot, and I. M. C. M. Rietjens, “Enforcement of the ban on aristolochic acids in Chinese traditional herbal preparations on the Dutch market,” Analytical and Bioanalytical Chemistry, vol. 389, no. 1, pp. 263–275, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. X. J. Liu and S. B. Su, “Study of combination methods for formula composition of Chinese herbal medicines and their components,” Journal of Chinese Integrative Medicine, vol. 7, no. 7, pp. 601–606, 2009 (Chinese). View at Publisher · View at Google Scholar · View at Scopus
  14. J. Qiu, “Traditional medicine: a culture in the balance,” Nature, vol. 448, no. 7150, pp. 126–128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Liu, Y. Gao, R. Xiao, and B. L. Zhang, “Fuzzy mathematic quantitative law of composing principle in the study of traditional Chinese medicine,” Yaoxue Xuebao, vol. 44, no. 1, pp. 38–41, 2009 (Chinese). View at Google Scholar · View at Scopus
  16. B. T. Schaneberg and I. A. Khan, “Analysis of products suspected of containing Aristolochia or Asarum species,” Journal of Ethnopharmacology, vol. 94, no. 2-3, pp. 245–249, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Laing, S. Hamour, M. Sheaff, R. Miller, and R. Woolfson, “Chinese herbal uropathy and nephropathy,” The Lancet, vol. 368, no. 9532, p. 338, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Zhang and M. Xie, “The nephrotoxicity in rats caused by Longdan Xiegan decoction,” Zhongguo Zhongyao Zazhi, vol. 31, no. 10, pp. 836–839, 2006. View at Google Scholar · View at Scopus
  19. C. Liu, A. Tseng, and S. Yang, Chinese Herbal Medicine: Modern Applications of Traditional Formulas, CRC Press, Boca Raton, Fla, USA, 2005.
  20. J. K. Nicholson, J. C. Lindon, and E. Holmes, “'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data,” Xenobiotica, vol. 29, no. 11, pp. 1181–1189, 1999. View at Google Scholar · View at Scopus
  21. O. Fiehn, “Metabolomics—the link between genotypes and phenotypes,” Plant Molecular Biology, vol. 48, no. 1-2, pp. 155–171, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. G. A. N. Gowda, S. Zhang, H. Gu, V. Asiago, N. Shanaiah, and D. Raftery, “Metabolomics-based methods for early disease diagnostics,” Expert Review of Molecular Diagnostics, vol. 8, no. 5, pp. 617–633, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Mayr, “Metabolomics: ready for the prime time?” Circulation, vol. 1, no. 1, pp. 58–65, 2008. View at Google Scholar · View at Scopus
  24. R. D. Beger, J. Sun, and L. K. Schnackenberg, “Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity,” Toxicology and Applied Pharmacology, vol. 243, no. 2, pp. 154–166, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Zhang, H. Wu, P. Liao, X. Li, J. Ni, and F. Pei, “NMR-based metabonomic study on the subacute toxicity of aristolochic acid in rats,” Food and Chemical Toxicology, vol. 44, no. 7, pp. 1006–1014, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. Q. Liang, C. Ni, M. Xie et al., “Nephrotoxicity study of Aristolochia fangchi in rats by metabonomics,” Journal of Chinese Integrative Medicine, vol. 7, no. 8, pp. 746–752, 2009 (Chinese). View at Publisher · View at Google Scholar · View at Scopus
  27. M. Chen, M. Su, L. Zhao et al., “Metabonomic study of aristolochic acid-induced nephrotoxicity in rats,” Journal of Proteome Research, vol. 5, no. 4, pp. 995–1002, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Coen, E. Holmes, J. C. Lindon, and J. K. Nicholson, “NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology,” Chemical Research in Toxicology, vol. 21, no. 1, pp. 9–27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Shackelford, G. Long, J. Wolf, C. Okerberg, and R. Herbert, “Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies,” Toxicologic Pathology, vol. 30, no. 1, pp. 93–96, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. R Development Core Team, R: A Language and Environment for Statistical Computing, R Development Core Team, Vienna, Austria, 2010.
  31. F. Dieterle, A. Ross, G. Schlotterbeck, and H. Senn, “Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures: application in 1H NMR metabonomics,” Analytical Chemistry, vol. 78, no. 13, pp. 4281–4290, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. U. G. Indahl, H. Martens, and T. Næs, “From dummy regression to prior probabilities in PLS-DA,” Journal of Chemometrics, vol. 21, no. 12, pp. 529–536, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. B. H. Mevik and R. Wehrens, “The pls package: principal component and partial least squares regression in R,” Journal of Statistical Software, vol. 18, no. 2, pp. 1–23, 2007. View at Google Scholar · View at Scopus
  34. J. A. Westerhuis, E. J. J. van Velzen, H. C. J. Hoefsloot, and A. K. Smilde, “Discriminant Q2 (DQ2) for improved discrimination in PLSDA models,” Metabolomics, vol. 4, no. 4, pp. 293–296, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Lundstedt, E. Seifert, L. Abramo et al., “Experimental design and optimization,” Chemometrics and Intelligent Laboratory Systems, vol. 42, no. 1-2, pp. 3–40, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. D. S. Wishart, D. Tzur, C. Knox et al., “HMDB: the human metabolome database,” Nucleic Acids Research, vol. 35, no. 1, pp. D521–D526, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. M. E. Bollard, H. C. Keun, O. Beckonert et al., “Comparative metabonomics of differential hydrazine toxicity in the rat and mouse,” Toxicology and Applied Pharmacology, vol. 204, no. 2, pp. 135–151, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. F. P. J. Martin, M. E. Dumas, Y. Wang et al., “A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model,” Molecular Systems Biology, vol. 3, p. 112, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Sato, D. Takahashi, S. M. Chen et al., “Acute nephrotoxicity of aristolochic acids in mice,” Journal of Pharmacy and Pharmacology, vol. 56, no. 2, pp. 221–229, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. X. Xue, Y. Xiao, H. Zhu et al., “Induction of P450 1A by 3-methylcholanthrene protects mice from aristolochic acid-I-induced acute renal injury,” Nephrology Dialysis Transplantation, vol. 23, no. 10, pp. 3074–3081, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Shibutani, H. Dong, N. Suzuki, S. Ueda, F. Miller, and A. P. Grollman, “Selective toxicity of aristolochic acids I and II,” Drug Metabolism and Disposition, vol. 35, no. 7, pp. 1217–1222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. E. M. Lenz, J. Bright, R. Knight et al., “Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat,” Biomarkers, vol. 10, no. 2-3, pp. 173–187, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Sieber, D. Hoffmann, M. Adler et al., “Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity,” Toxicological Sciences, vol. 109, no. 2, pp. 336–349, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. K. P. R. Gartland, F. W. Bonner, and J. K. Nicholson, “Investigations into the biochemical effects of region-specific nephrotoxins,” Molecular Pharmacology, vol. 35, no. 2, pp. 242–250, 1989. View at Google Scholar · View at Scopus
  45. E. Holmes, F. W. Bonner, and J. K. Nicholson, “Comparative studies on the nephrotoxicity of 2-bromoethanamine hydrobromide in the Fischer 344 rat and the multimammate desert mouse (Mastomys natalensis),” Archives of Toxicology, vol. 70, no. 2, pp. 89–95, 1995. View at Google Scholar · View at Scopus
  46. A. A. Kandutsch and A. E. Russell, “Creatine and creatinine in tissues and urine of mice with hereditary muscular dystrophy,” The American Journal of Physiology, vol. 194, no. 3, pp. 553–556, 1958. View at Google Scholar · View at Scopus